Delivery Order SPE2DB22D3004-SPE2DB24FRK99
Award Date
8/13/24
Potential Completion Date
8/14/24
Potential Value
$3.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, SPE2DX15D3017|SPE2DX25F0JHB, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ACTEMRA ACTPEN 162 MG/0.9 ML 0.9ML, a medical supply item, with a ceiling value of $1,426.74 and a completion date of December 4, 2024. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at...
This federal contract award is for the delivery of the pharmaceutical product ACTEMRA ACTPEN 162 MG/0.9 ML 0.9ML to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $2,630.88, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on August 9, 2024, with a completion date of August 12, 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $6,384.37 firm-fixed-price delivery order is for the supply of ACTEMRA ACTPEN 162 MG/0.9 ML 0.9ML, a specialty injectable medication. The award has an ultimate completion date of October 11, 2024 and does not have a set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This federal contract award, valued at $30,884.63, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract is for the delivery of ACTEMRA ACTPEN 162 MG/0.9 ML 0.9ML, a specialty pharmaceutical product, to support military treatment programs and facilities. This contract award is a delivery order under a larger indefinite delivery contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $33,397.75 Firm Fixed Price Delivery Order is for the supply of ACTEMRA ACTPEN 162 MG/0.9 ML 0.9ML, a pharmaceutical product, to support military healthcare programs. The contract has an ultimate completion date of November 5, 2024 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999...
This federal contract award is for the delivery of ACTEMRA ACTPEN 162 MG/0.9 ML 0.9ML, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The $4,384.02 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, which serves as a primary vehicle for...
This federal contract award, valued at $1,375.80, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. The contract is for the delivery of ACTEMRA ACTPEN 162 MG/0.9 ML 0.9ML, a pharmaceutical product, with a completion date of December 6, 2024. The contract is a Delivery Order under a Firm Fixed Price arrangement, and it does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $46,649.47 firm-fixed-price delivery order is for the supply of ACTEMRA ACTPEN 162 MG/0.9 ML 0.9ML, a specialty medication. The contract has an ultimate completion date of October 17, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The $6,083.31 Firm Fixed Price contract is for the delivery of ACTEMRA ACTPEN 162 MG/0.9 ML 0.9ML, a specialty medication, to support military treatment programs and facilities globally. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999.00, which serves as the...
This federal contract award, valued at $13,213.09, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is a Delivery Order for the pharmaceutical product ACTEMRA ACTPEN 162 MG/0.9 ML 0.9ML and does not have a set-aside designation. Amerisourcebergen is a major pharmaceutical distributor that plays a critical role in supplying medical products to federal government agencies, particularly the military and veterans' healthcare...